Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT.

scientific article published on July 2010

Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1148/RADIOL.10091295
P698PubMed publication ID20574090

P50authorValérie ParadisQ39574809
Bernard E Van BeersQ60658822
Tarik AsselahQ87747573
Maxime RonotQ89798238
Patrick MarcellinQ89798262
Valérie VilgrainQ90387260
P2093author name stringNicolas Michoux
Gabriel Baron
Mylène Dorvillius
P433issue1
P407language of work or nameEnglishQ1860
P921main subjecthepatitis CQ154869
Hepatitis C virusQ708693
chronic hepatitis CQ55779873
chronic hepatitisQ62019625
P304page(s)135-142
P577publication date2010-07-01
P1433published inRadiologyQ3285690
P1476titleLiver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT
P478volume256

Reverse relations

cites work (P2860)
Q88734990Accuracy and precision of quantitative DCE-MRI parameters: How should one estimate contrast concentration?
Q52981971Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.
Q53060987Assessing liver fibrosis: comparison of arterial enhancement fraction and diffusion-weighted imaging.
Q50224570Assessment of liver fibrosis by ultrasound elastography and contrast-enhanced ultrasound: a randomized prospective animal study
Q41826282Assessment of liver fibrosis in the early stages with perfusion CT.
Q56526856CT predicts liver fibrosis: Prospective evaluation of morphology- and attenuation-based quantitative scores in routine portal venous abdominal scans
Q47331718Computed tomography perfusion study of hemodynamic changes and portal hyperperfusion in a rabbit model of small-for-size liver.
Q30417029Contrast-enhanced ultrasonography for the evaluation of liver fibrosis after biliary obstruction.
Q33759248DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility
Q88674298Diagnostic Performance of Shear Wave Elastography in Patients With Autoimmune Liver Disease
Q36296611Diminished liver microperfusion in Fontan patients: A biexponential DWI study
Q37938908Dual-phase computed tomography for assessment of pancreatic fibrosis and anastomotic failure risk following pancreatoduodenectomy
Q37924180Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
Q37478899Effect of dual vascular input functions on CT perfusion parameter values and reproducibility in liver tumors and normal liver
Q39380465Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.
Q37535574Evaluation of hepatic tissue blood flow using xenon computed tomography with fibrosis progression in nonalcoholic fatty liver disease: comparison with chronic hepatitis C
Q40261026Evaluation of splenic perfusion and spleen size using dynamic computed tomography: Usefulness in assessing degree of liver fibrosis.
Q64234105Hepatic blood flow by perfusion computed tomography as an imaging biomarker for patients with gastric cancer
Q34089545Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI
Q47111287Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study
Q64084110Intravoxel incoherent motion derived liver perfusion/diffusion readouts can be reliable biomarker for the detection of viral hepatitis B induced liver fibrosis
Q34029802Investigation of hepatic blood perfusion by laser speckle imaging and changes of hepatic vasoactive substances in mice after electroacupuncture
Q38162372Latest developments in the imaging of fibrotic liver disease
Q92157429Liver Fibrosis Conventional and Molecular Imaging Diagnosis Update
Q53091983Liver dynamic contrast-enhanced MRI for staging liver fibrosis in a piglet model.
Q92665904Liver injury monitoring, fibrosis staging and inflammation grading using T1rho magnetic resonance imaging: an experimental study in rats with carbon tetrachloride intoxication
Q39412838Liver volume is a prognostic indicator for clinical outcome of patients with alcoholic hepatitis.
Q38450422Measurement of Tissue interstitial volume in healthy patients and those with amyloidosis with equilibrium contrast-enhanced MR imaging.
Q37876335New acquisition techniques: fields of application
Q26778033Non-invasive diagnosis of liver fibrosis and cirrhosis
Q30436164Noninvasive diagnosis of cirrhosis: a review of different imaging modalities
Q26740195Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection
Q41355591Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging
Q26795413Prediction of liver cirrhosis, using diagnostic imaging tools
Q53161318Prediction of pancreatic anastomotic failure after pancreatic head resection using preoperative diffusion-weighted MR imaging.
Q41960226Preoperative hepatic CT perfusion as an early predictor for the recurrence of esophageal squamous cell carcinoma: initial clinical results
Q37394878Quantitative characterization of hepatocellular carcinoma and metastatic liver tumor by CT perfusion.
Q30428521Real time shear wave elastography in chronic liver diseases: accuracy for predicting liver fibrosis, in comparison with serum markers
Q30448049Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma
Q52984676Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension.
Q30389962Shear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurement
Q64910147Short-term changes observed in multiparametric liver MRI following therapy with direct-acting antivirals in chronic hepatitis C virus patients.
Q39199815Validation of Shear Wave Elastography Cutoff Values on the Supersonic Aixplorer for Practical Clinical Use in Liver Fibrosis Staging

Search more.